GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Henan Taloph Pharmaceutical Stock Co 600222.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

6.61

+2.01%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.76bn

FY2016FY2025

Net income

CN¥60.0m

FY2016FY2025

Free cash flow

CN¥26.0m

FY2016FY2025

Shareholders' equity

CN¥1.60bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥1.76bnCN¥1.94bnCN¥2.07bnCN¥1.96bnCN¥1.60bnCN¥1.42bnCN¥1.31bnCN¥1.19bnCN¥1.17bnCN¥953.3m
Research and developmentCN¥67.8mCN¥100.9mCN¥127.7mCN¥116.5mCN¥56.5mCN¥63.7mCN¥59.4mCN¥58.1mCN¥40.6mCN¥41.3m
Operating incomeCN¥136.0mCN¥35.7mCN¥44.2m−CN¥17.1mCN¥91.5mCN¥33.0mCN¥50.5mCN¥73.7mCN¥21.9mCN¥7.4m
Net incomeCN¥60.0mCN¥50.5mCN¥43.6m−CN¥72.2mCN¥6.0mCN¥29.2mCN¥44.4m−CN¥115.3mCN¥5.1mCN¥4.0m
Diluted earnings per share0.110.090.08-0.130.010.050.08-0.200.010.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥3.64bnCN¥3.49bnCN¥3.58bnCN¥3.60bnCN¥3.78bnCN¥3.39bnCN¥2.74bnCN¥2.84bnCN¥2.81bnCN¥2.65bn
Cash and short-term investments—CN¥260.1mCN¥350.0mCN¥386.3mCN¥666.2mCN¥694.8mCN¥574.5mCN¥799.6mCN¥669.1mCN¥585.7m
Total liabilitiesCN¥1.98bnCN¥1.86bnCN¥1.95bnCN¥1.99bnCN¥2.01bnCN¥1.86bnCN¥1.43bnCN¥1.44bnCN¥1.30bnCN¥1.15bn
DebtCN¥61.8mCN¥678.5mCN¥819.3mCN¥665.9mCN¥1.18bnCN¥1.32bnCN¥1.14bnCN¥1.19bnCN¥1.06bnCN¥964.5m
Shareholders' equityCN¥1.60bnCN¥1.57bnCN¥1.58bnCN¥1.57bnCN¥1.66bnCN¥1.45bnCN¥1.38bnCN¥1.39bnCN¥1.49bnCN¥1.48bn
Shares outstanding553m556m558m562m557m549m553m567m595m550m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥47.2m−CN¥39.6mCN¥43.7m−CN¥124.4mCN¥99.7mCN¥73.4mCN¥41.5mCN¥119.5mCN¥23.2mCN¥70.6m
Capital spending−CN¥21.1m−CN¥37.2m−CN¥43.1m−CN¥66.6m−CN¥39.1m−CN¥72.7m−CN¥107.7m−CN¥66.4m−CN¥44.3m−CN¥59.6m
Free cash flowCN¥26.0m−CN¥76.8mCN¥605,000−CN¥191.0mCN¥60.6mCN¥775,000−CN¥66.2mCN¥53.1m−CN¥21.2mCN¥11.0m
Dividends paid−CN¥50.8m−CN¥69.1m−CN¥50.2m−CN¥5.6m−CN¥84.6m−CN¥65.5m−CN¥60.0m−CN¥67.0m−CN¥55.6m−CN¥70.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥387.8mCN¥350.2mCN¥570.9mCN¥424.5mCN¥439.2mCN¥323.3mCN¥600.7mCN¥413.4m
Operating incomeCN¥18.1mCN¥19.6mCN¥92.7mCN¥26.6mCN¥21.9mCN¥17.0mCN¥11.0mCN¥2.8m
Net incomeCN¥9.4mCN¥2.6mCN¥34.7mCN¥6.0mCN¥17.8mCN¥1.5mCN¥21.6mCN¥2.3m
Diluted earnings per share0.020.000.060.010.030.000.040.00
Cash from operations———CN¥22.0m−CN¥122.0mCN¥10.0mCN¥57.0m−CN¥4.0m
Capital spending−CN¥1.0m−CN¥3.0m−CN¥9.0m−CN¥5.0m−CN¥2.0m−CN¥4.0m−CN¥27.0m−CN¥2.0m
Free cash flow———CN¥17.0m−CN¥124.0mCN¥6.0mCN¥30.0m−CN¥6.0m
Total assetsCN¥3.63bnCN¥3.68bnCN¥3.64bnCN¥3.74bnCN¥3.58bnCN¥3.57bnCN¥3.49bnCN¥3.72bn
Cash and short-term investments———CN¥343.9mCN¥245.8mCN¥403.9mCN¥260.1mCN¥397.8m
DebtCN¥197.2mCN¥221.5mCN¥61.8mCN¥891.6mCN¥1.04bnCN¥798.1mCN¥666.4mCN¥607.1m
Shareholders' equityCN¥1.61bnCN¥1.61bnCN¥1.60bnCN¥1.59bnCN¥1.60bnCN¥1.58bnCN¥1.57bnCN¥1.57bn

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin7.6%5.0%2.1%-0.9%0.8%7.4%
Net margin3.4%2.6%2.1%-3.7%0.4%2.1%
Return on equity3.7%3.2%2.8%-4.6%0.4%2.0%
Return on assets1.6%1.4%1.2%-2.0%0.2%0.9%
Free cash flow yield1.8%-0.1%2.2%-1.5%3.5%3.8%
Revenue growth-9.5%-6.2%5.6%22.2%13.2%8.0%
Earnings growth18.7%16.0%-160.3%-1304.3%-79.5%-34.2%
Current ratio1.14x1.06x1.21x1.18x1.18x1.25x
Debt to equity0.04x0.42x0.41x0.38x0.69x0.61x
Equity ratio44.1%45.1%44.1%43.6%43.9%42.9%
Interest coverage2.40x1.57x47.83x-0.26x0.15x1.39x
R&D as a share of sales3.9%5.2%6.2%5.9%3.5%4.5%
Buybacks as a share of market value0.4%0.5%0.6%-0.9%-1.5%0.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-3.6%4.4%5.6%
Operating income—32.7%—
Net income—15.5%26.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin4.6%2.6%3.0%2.9%
Net margin3.0%1.1%1.1%0.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings60.856.078.6-49.5—94.056.9-16.7——
Price to sales2.11.51.61.83.11.91.91.62.74.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 9 Jan 2026.

FY2025FY2024FY2022FY2021FY2018FY2015FY2014FY2010
Paid in the year0.0140.0280.010.0160.010.010.0250.009
  • 11-for-10 split · 3 Jun 2008
  • 1.894-for-1 split · 4 Sept 2006
  • 1.118-for-1 split · 28 Aug 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.